A modern cultural and social debate pitting the body positivity movement—which champions self-acceptance and appreciation of all body sizes against fat-shaming—against the explosive rise of GLP-1 receptor agonist drugs (such as semaglutide in Ozempic and Wegovy), which promote rapid weight loss and challenge ideals of body diversity.

The tension in wellness discourse between embracing one's body 'as is' and embracing pharmaceutical interventions for slimmer figures, often highlighted in social media and influencer circles.

A crossroads for body image advocacy, where GLP-1 medications' popularity prompts questions about whether 'love your body at any size' still holds when sizes can be medically altered.